Wahed Invest’s Moderna MRNA Stock Holding History

Wahed Invest’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,266	Closed	-$655K	–	238
2023 Q1	$655K	Sell	4,266 -286	-6%	-$47.2K	0.28%	60
2022 Q4	$818K	Buy	+4,552	New	+$744K	0.42%	44

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wahed Invest's MRNA Position: Q2 2023 in Review

Wahed Invest sold out of Moderna (MRNA) in Q2 2023, closing a stake of 4,266 shares — an estimated $655K sold.

Wahed Invest first reported a position in MRNA in Q4 2022 and held it in 2 quarters. The position peaked at $818K in Q4 2022. 966 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

Wahed Invest reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
Wahed Invest sold 4,266 Moderna shares in Q2 2023, an estimated $655K.
Wahed Invest first reported a position in Moderna in Q4 2022 and held it in 2 quarters.
Wahed Invest's Moderna position peaked at $818K in Q4 2022.
966 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Wahed Invest's 13F filing for Q2 2023, filed 14 Aug 2023.